Livingston Memorial Visiting Nurse Association - H Medicare Approved Location: 1996 Eastman Ave Ste 108, Ventura, California 93003 Phone: (805) 642-1608 |
Assisted Home Hospice Medicare Approved Location: 4450 Westinghouse Street, Suite #103, Ventura, California 93003 Phone: (805) 677-7400 |
Roze Room Hospice Of Ventura Medicare Approved Location: 5675 Ralston St Ste C, Ventura, California 93003 Phone: (805) 654-0191 |
Community Care And Hospice Medicare Approved Location: 2941 Loma Vista Road, Ventura, California 93003 Phone: (805) 667-8558 |
News Archive
The U.S. Food and Drug Administration today warned that the unapproved use of the malaria drug Qualaquin (quinine sulfate) to treat night time leg cramps has resulted in serious side effects and prompted the manufacturer to develop a risk management plan aimed at educating health care professionals and patients about the potential risks.
The euroPLX pharma business development platform is preparing to celebrate its 50th partnering conference on 5 and 6 November 2012 in Sorrento, Italy. Currently held three times a year, euroPLX has been held for the first time in 1995 as the first no-lectures, no-presentations business partnering conference of the life science and pharmaceutical industry worldwide.
Air quality has been associated with numerous adverse health outcomes from asthma to pre-term birth. Researchers at University of Utah Health found women living along the Wasatch Front - the most populous region in the state of Utah - had a higher risk (16 percent) of miscarriage following short-term exposure to elevated air pollution. The results are available online on December 5 in the journal Fertility and Sterility.
Techne Corporation announced today that it has acquired 100% ownership of Tocris Holdings Limited and subsidiaries, a leading supplier of reagents for non-clinical life science research.
La Jolla Pharmaceutical Company provided an update today that the Company is actively seeking and evaluating potential pharmaceutical products for in-licensing or acquisition and has engaged consultants to determine whether there is any potential for the further development of Riquent for the treatment of lupus.
› Verified 9 days ago